Samaras et al. performed a comparative immunohistochemical analysis of Aurora-A and Aurora-B expression in 40 patients with primary glioblastomas to identify possible correlations with Ki-67 proliferation index and clinical outcomes (70). Here, AURKB is linked to glioblastoma.